Literature DB >> 14585336

Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3.

Andreas Henke1, Roland Zell, Ulrike Martin, Axel Stelzner.   

Abstract

Coxsackievirus B3 (CVB3) is one of the most important causes of viral myocarditis. Cytokines are involved in the control of CVB3 replication and pathogenesis. Local expression of specific cytokines by recombinant CVB3 confers prevention of virus-caused myocarditis. Expression of IFN-gamma by CVB3(IFN-gamma) protected BALB/c and C57BL/6 mice when the lethal infection with the highly pathogenic CVB3H3 variant was given directly after or prior to CVB3(IFN-gamma) inoculation by decreasing the viral load and spread as well as tissue destruction. This direct effect was not restricted to the homologous virus. In vitro, cocultivation of CVB3(IFN-gamma)-infected cells induced a reduction of CVB3H3 replication and virus-induced cytopathogenicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14585336     DOI: 10.1016/s0042-6822(03)00538-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.

Authors:  Mauro Pires Moraes; Teresa de Los Santos; Marla Koster; Traci Turecek; He Wang; Vladimir G Andreyev; Marvin J Grubman
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

2.  Amelioration of coxsackievirus B3-mediated myocarditis by inhibition of tissue inhibitors of matrix metalloproteinase-1.

Authors:  Stephen J Crocker; Ricardo F Frausto; Jason K Whitmire; Nicola Benning; Richard Milner; J Lindsay Whitton
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

3.  Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.

Authors:  S Van Linthout; K Savvatis; K Miteva; J Peng; J Ringe; K Warstat; C Schmidt-Lucke; M Sittinger; H-P Schultheiss; C Tschöpe
Journal:  Eur Heart J       Date:  2010-12-22       Impact factor: 29.983

4.  Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.

Authors:  Kapka Miteva; Marion Haag; Jun Peng; Kostas Savvatis; Peter Moritz Becher; Martina Seifert; Katrin Warstat; Dirk Westermann; Jochen Ringe; Michael Sittinger; Heinz-Peter Schultheiss; Carsten Tschöpe; Sophie Van Linthout
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

5.  Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy.

Authors:  Kapka Miteva; Sophie Van Linthout; Hans-Dieter Volk; Carsten Tschöpe
Journal:  Stem Cells Int       Date:  2013-06-19       Impact factor: 5.443

6.  The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy.

Authors:  Li Yue-Chun; Chen Guang-Yi; Ge Li-Sha; Xing Chao; Tian Xinqiao; Lin Cong; Dai Xiao-Ya; Yang Xiangjun
Journal:  Front Pharmacol       Date:  2016-11-01       Impact factor: 5.810

Review 7.  Molecular Pathogenicity of Enteroviruses Causing Neurological Disease.

Authors:  Anna Majer; Alan McGreevy; Timothy F Booth
Journal:  Front Microbiol       Date:  2020-04-09       Impact factor: 5.640

8.  Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis.

Authors:  Ge Li-Sha; Liu Li; Zhou De-Pu; Shi Zhe-Wei; Gu Xiaohong; Chen Guang-Yi; Li Jia; Lin Jia-Feng; Chu Maoping; Li Yue-Chun
Journal:  Front Pharmacol       Date:  2018-03-05       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.